Note: Ingredients listed on restricted chemical lists
EC/CAS
200-018-0/50-21-5
Name of the chemical
lactic acid
Concentration
>=1-<3
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
>=1-<2
General Information
Version
5.3
Revision date
2023-09-30
Product name
Orbifloxacin Liquid Formulation
1.2.1 Relevant identified uses
Veterinary product
Emergency telephone
+27119239300, +1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d, H373
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H361d Suspected of damaging the unborn child. H373 May cause damage to organs (Eye) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Hazardous Ingredients
Orbifloxacin
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Reproductive toxicity, Category 2 H361d: Suspected of damaging the unborn child. Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2, Eye longed or repeated exposure if swallowed.
